IV Compounding Robots

December 2021 - Vol.18 No. 12 - Page #6
Category: Robotic IV Preparation Devices

Robot implementations remain concentrated in large teaching hospitals with a strong commitment to USP compliance. As expertise with this automation grows, these facilities are reaping additional benefits. This year saw a decrease in the number of staff assigned to manage the robots with a simultaneous expansion to running the robots on multiple shifts. Looking ahead, interest in this automation is expanding to mid-sized facilities as more pharmacies look to automate both HD and non-HD sterile compounding.

While most robot users produce less than 10% of their total doses via a robot, one-third of facilities leverage their robots for a significant portion of their total doses.

Overall, 11% of facilities are looking to add robots to automate their IV production. Facilities considering these devices are evenly split between mid- and large-size facilities.

Most facilities are reviewing a variety of vendors as they explore robots for both standard compounding and for HD compounding. Omnicell, Grifols, and Equashield are the leading vendors under consideration.


Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue